相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Alterations in plasma membrane ion channel structures stimulate NLRP3 inflammasome activation in APOL1 risk milieu
Alok Jha et al.
FEBS JOURNAL (2020)
On macrophage diversity and inflammatory metabolic timers
Peter J. Murray
NATURE REVIEWS IMMUNOLOGY (2020)
Macrophages: versatile players in renal inflammation and fibrosis
Patrick Ming-Kuen Tang et al.
NATURE REVIEWS NEPHROLOGY (2019)
Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
Yang Yang et al.
CELL DEATH & DISEASE (2019)
Macrophage plasticity, polarization and function in response to curcumin, a diet-derived polyphenol, as an immunomodulatory agent
Asadollah Mohammadi et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2019)
M2 macrophages in kidney disease: biology, therapies, and perspectives
Titi Chen et al.
KIDNEY INTERNATIONAL (2019)
The role of inflammasomes in kidney disease
Takanori Komada et al.
NATURE REVIEWS NEPHROLOGY (2019)
APOL1 renal risk variants promote cholesterol accumulation in tissues and cultured macrophages from APOL1 transgenic mice
Jung-Hwa Ryu et al.
PLOS ONE (2019)
Human Monocyte Subsets and Phenotypes in Major Chronic Inflammatory Diseases
Theodore S. Kapellos et al.
FRONTIERS IN IMMUNOLOGY (2019)
Inflammation in Renal Diseases: New and Old Players
Vinicius Andrade-Oliveira et al.
FRONTIERS IN PHARMACOLOGY (2019)
High Levels of IL-18 and IFN-γ in Chronically Inflamed Tissue in Chronic Granulomatous Disease
Virginia Meda Spaccamela et al.
FRONTIERS IN IMMUNOLOGY (2019)
Zoledronic acid promotes TLR-4-mediated M1 macrophage polarization in bisphosphonate-related osteonecrosis of the jaw
Weiwen Zhu et al.
FASEB JOURNAL (2019)
Antisense oligonucleotide treatment ameliorates IFN-γ-induced proteinuria in APOL1-transgenic mice
Mariam Aghajan et al.
JCI INSIGHT (2019)
Macrophage polarization in chronic kidney disease: a balancing act between renal recovery and decline?
Jason E. Engel et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2019)
The NLRP3 inflammasome modulates glycolysis by increasing PFKFB3 in an IL-1β-dependent manner in macrophages
Orla M. Finucane et al.
SCIENTIFIC REPORTS (2019)
Wnt/beta-Catenin-Promoted Macrophage Alternative Activation Contributes to Kidney Fibrosis
Ye Feng et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Inhibition of the NLRP3 inflammasome attenuates foam cell formation of THP-1 macrophages by suppressing ox-LDL uptake and promoting cholesterol efflux
Liang Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Simultaneous activation of innate and adaptive immunity participates in the development of renal injury in a model of heavy proteinuria
Viviane Dias Faustino et al.
BIOSCIENCE REPORTS (2018)
Metabolic regulation of macrophages in tissues
Jan Van den Bossche et al.
CELLULAR IMMUNOLOGY (2018)
Apolipoprotein L1 nephropathies: 2017 in review
Jeffrey B. Kopp et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2018)
M1/M2 Macrophages in Diabetic Nephropathy: Nrf2/HO-1 as Therapeutic Targets
Robert Clive Landis et al.
CURRENT PHARMACEUTICAL DESIGN (2018)
The metabolic axis of macrophage and immune cell polarization
Spencer A. Hobson-Gutierrez et al.
DISEASE MODELS & MECHANISMS (2018)
Chronic kidney disease induces inflammation by increasing Toll-like receptor-4, cytokine and cathelicidin expression in neutrophils and monocytes
Caren C. Grabulosa et al.
EXPERIMENTAL CELL RESEARCH (2018)
The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1-mediated tissue injury
Hans-Joachim Anders et al.
KIDNEY INTERNATIONAL (2018)
A positive feedback loop between IL-1 beta, LPS and NEU1 may promote atherosclerosis by enhancing a pro-inflammatory state in monocytes and macrophages
Irina Sieve et al.
VASCULAR PHARMACOLOGY (2018)
Chronic kidney disease alters lipid trafficking and inflammatory responses in macrophages: effects of liver X receptor agonism
Ryohei Kaseda et al.
BMC NEPHROLOGY (2018)
Innate immunity and Toll-like receptor signaling in the pathogenesis of scleroderma: advances and opportunities for therapy
Max Brown et al.
CURRENT OPINION IN RHEUMATOLOGY (2018)
Pharmacological Inhibition of Toll-Like Receptor-4 Signaling by TAK242 Prevents and Induces Regression of Experimental Organ Fibrosis
Swati Bhattacharyya et al.
FRONTIERS IN IMMUNOLOGY (2018)
NLRP3 Inflammasome: A Possible Link Between Obesity-Associated Low-Grade Chronic Inflammation and Colorectal Cancer Development
Patricia Ahechu et al.
FRONTIERS IN IMMUNOLOGY (2018)
ApoL1 renal risk variants induce aberrant THP-1 monocyte differentiation and increase eicosanoid production via enhanced expression of cyclooxygenase-2
Hewang Lee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2018)
Microbial stimulation of different Toll-like receptor signalling pathways induces diverse metabolic programmes in human monocytes
Ekta Lachmandas et al.
NATURE MICROBIOLOGY (2017)
Relaxin abrogates renal interstitial fibrosis by regulating macrophage polarization via inhibition of Toll-like receptor 4 signaling
Lei Chen et al.
ONCOTARGET (2017)
Infiltration of M1, but not M2, macrophages is impaired after unilateral ureter obstruction in Nrf2-deficient mice
Yuji Sogawa et al.
SCIENTIFIC REPORTS (2017)
NLRP3 inflammasome: Pathogenic role and potential therapeutic target for IgA nephropathy
Yu-Ling Tsai et al.
SCIENTIFIC REPORTS (2017)
Innate And Adaptive Immunity are Progressively Activated in Parallel with Renal Injury in the 5/6 Renal Ablation Model
Camilla Fanelli et al.
SCIENTIFIC REPORTS (2017)
The Origins and Functions of Tissue-Resident Macrophages in Kidney Development
David A. D. Munro et al.
FRONTIERS IN PHYSIOLOGY (2017)
Toll-like Receptor 4 Deficiency Reduces Oxidative Stress and Macrophage Mediated Inflammation in Hypertensive Kidney
Sathnur Pushpakumar et al.
SCIENTIFIC REPORTS (2017)
TLR2 stimulation impairs anti-inflammatory activity of M2-like macrophages, generating a chimeric M1/M2 phenotype
Lilian Quero et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Assessment of Tocilizumab (Anti-Interleukin-6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy in HLA-Sensitized Renal Allograft Recipients
J. Choi et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
Metabolic Instruction of Immunity
Michael D. Buck et al.
CELL (2017)
Treatment of Renal Fibrosis-Turning Challenges into Opportunities
Barbara M. Klinkhammer et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2017)
Integrative Genomics Identifies Novel Associations with APOL1 Risk Genotypes in Black NEPTUNE Subjects
Matthew G. Sampson et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Transfusion of CD206+ M2 Macrophages Ameliorates Antibody-Mediated Glomerulonephritis in Mice
Qiuna Du et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
The critical role of toll-like receptors - From microbial recognition to autoimmunity: A comprehensive review
Maximiliano Javier Jimenez-Dalmaroni et al.
AUTOIMMUNITY REVIEWS (2016)
Inflammation and Progression of CKD: The CRIC Study
Richard L. Amdur et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
IL-1β promotes tubulointerstitial injury in MPO-ANCA-associated glomerulonephritis
Manabu Tashiro et al.
CLINICAL NEPHROLOGY (2016)
Prostaglandin E2 promotes M2 polarization of macrophages via a cAMP/CREB signaling pathway and deactivates granulocytes in teleost fish
Jana Montero et al.
FISH & SHELLFISH IMMUNOLOGY (2016)
Molecular mechanisms of regulation of Toll-like receptor signaling
Cynthia A. Leifer et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
The global burden of chronic kidney disease: estimates, variability and pitfalls
Richard J. Glassock et al.
Nature Reviews Nephrology (2016)
Regulatory T cells in immune-mediated renal disease
Joanna R. Ghali et al.
NEPHROLOGY (2016)
The NLRP3 inflammasome in kidney disease and autoimmunity
Holly L. Hutton et al.
NEPHROLOGY (2016)
Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1
Brendan Nichols et al.
KIDNEY INTERNATIONAL (2015)
Human trypanolytic factor APOL1 forms pH-gated cation-selective channels in planar lipid bilayers: Relevance to trypanosome lysis
Russell Thomson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
APOL1 Kidney Disease Risk Variants: An Evolving Landscape
Patrick D. Dummer et al.
SEMINARS IN NEPHROLOGY (2015)
TLR4 mutant mice are protected from renal fibrosis and chronic kidney disease progression
Ana C. P. Souza et al.
PHYSIOLOGICAL REPORTS (2015)
Hyperuricemia-induced NLRP3 activation of macrophages contributes to the progression of diabetic nephropathy
Su-Mi Kim et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2015)
The emerging role of the inflammasome in kidney diseases
Anthony Chang et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2014)
Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
Peter J. Murray et al.
IMMUNITY (2014)
Macrophage Phenotype Controls Long-Term AKI Outcomes-Kidney Regeneration versus Atrophy
Maciej Lech et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
The Innate Immune Factor Apolipoprotein L1 Restricts HIV-1 Infection
Harry E. Taylor et al.
JOURNAL OF VIROLOGY (2014)
Increased mitochondrial activity in renal proximal tubule cells from young spontaneously hypertensive rats
Hewang Lee et al.
KIDNEY INTERNATIONAL (2014)
Pattern recognition receptors and the inflammasome in kidney disease
Jaklien C. Leemans et al.
NATURE REVIEWS NEPHROLOGY (2014)
Canonical and non-canonical effects of the NLRP3 inflammasome in kidney inflammation and fibrosis
Georg Lorenz et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I, Healthy Subjects Study of Intravenous OPN-305, a Humanized Anti-TLR2 Antibody
M. Reilly et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Renal Protective Effects of Toll-like Receptor 4 Signaling Blockade in Type 2 Diabetic Mice
J. J. Cha et al.
ENDOCRINOLOGY (2013)
Abnormal High-Density Lipoprotein Induces Endothelial Dysfunction via Activation of Toll-like Receptor-2
Thimoteus Speer et al.
IMMUNITY (2013)
Human Lipopolysaccharide-binding Protein (LBP) and CD14 Independently Deliver Triacylated Lipoproteins to Toll-like Receptor 1 (TLR1) and TLR2 and Enhance Formation of the Ternary Signaling Complex
Diana Rose E. Ranoa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Role of the Toll Like Receptor (TLR) Radical Cycle in Chronic Inflammation: Possible Treatments Targeting the TLR4 Pathway
Kurt Lucas et al.
MOLECULAR NEUROBIOLOGY (2013)
Uric acid and chronic kidney disease: which is chasing which?
Richard J. Johnson et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Design, synthesis and biological evaluation of novel antagonist compounds of Toll-like receptors 7, 8 and 9
Ekambar R. Kandimalla et al.
NUCLEIC ACIDS RESEARCH (2013)
Interleukin-18, more than a Th1 cytokine
Daniela Novick et al.
SEMINARS IN IMMUNOLOGY (2013)
Role of macrophages in the fibrotic phase of rat crescentic glomerulonephritis
Yingjie Han et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2013)
Netrin-1-treated macrophages protect the kidney against ischemia-reperfusion injury and suppress inflammation by inducing M2 polarization
Punithavathi Vilapakkam Ranganathan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2013)
Genetic Risk Prediction for CKD: A Journey of a Thousand Miles
Jeffrey B. Kopp et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
MyD88 Signaling Pathway Is Involved in Renal Fibrosis by Favoring a TH2 Immune Response and Activating Alternative M2 Macrophages
Tarcio Teodoro Braga et al.
MOLECULAR MEDICINE (2012)
Knockout of Toll-Like Receptor-2 Attenuates Both the Proinflammatory State of Diabetes and Incipient Diabetic Nephropathy
Sridevi Devaraj et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Identification of alternatively activated macrophages in new-onset paediatric and adult immunoglobulin A nephropathy: potential role in mesangial matrix expansion
Yohei Ikezumi et al.
HISTOPATHOLOGY (2011)
APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated Nephropathy
Jeffrey B. Kopp et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis
Hans-Joachim Anders et al.
KIDNEY INTERNATIONAL (2011)
Toll-like receptor expression in monocytes in patients with chronic kidney disease and haemodialysis: relation with inflammation
Mehmet Koc et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Substrate Fate in Activated Macrophages: A Comparison between Innate, Classic, and Alternative Activation
Juan-Carlos Rodriguez-Prados et al.
JOURNAL OF IMMUNOLOGY (2010)
The NLRP3 Inflammasome Promotes Renal Inflammation and Contributes to CKD
Akosua Vilaysane et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
The trypanolytic factor of human serum: many ways to enter the parasite, a single way to kill
Benoit Vanhollebeke et al.
MOLECULAR MICROBIOLOGY (2010)
Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
Giulio Genovese et al.
SCIENCE (2010)
IL-18 is involved in vascular injury in end-stage renal disease patients
Tomasz Porazko et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Novel targets and new potential: developments in the treatment of inflammation in chronic kidney disease
Csaba P. Kovescly et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Apolipoprotein L-1 promotes trypanosome lysis by forming pores in lysosomal membranes
D Pérez-Morga et al.
SCIENCE (2005)
Macrophages transfected with adenovirus to express IL-4 reduce inflammation in experimental glomerulonephritis
DC Kluth et al.
JOURNAL OF IMMUNOLOGY (2001)
分享论文
